Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence of venous thromboembolism. METHODS: We randomly assigned 822 patients who had completed initial anticoagulant therapy after a first episode of unprovoked venous thromboembolism to receive aspirin, at a dose of 100 mg daily, or placebo for up to 4 years. The primary outcome was a recurrence of venous thromboembolism. RESULTS: During a median follow-up period of 37.2 months, venous thromboembolism recurred in 73 of 411 patients assigned to placebo and in 57 of 411 assigned to aspirin (a rate of 6.5% per year vs. 4.8% per year; hazard ratio with aspirin, 0.74; 95% confidence interval [CI], 0.52 to 1.05; P=0.09). Aspirin reduced the rate of the two prespecified secondary composite outcomes: the rate of venous thromboembolism, myocardial infarction, stroke, or cardiovascular death was reduced by 34% (a rate of 8.0% per year with placebo vs. 5.2% per year with aspirin; hazard ratio with aspirin, 0.66; 95% CI, 0.48 to 0.92; P=0.01), and the rate of venous thromboembolism, myocardial infarction, stroke, major bleeding, or death from any cause was reduced by 33% (hazard ratio, 0.67; 95% CI, 0.49 to 0.91; P=0.01). There was no significant between-group difference in the rates of major or clinically relevant nonmajor bleeding episodes (rate of 0.6% per year with placebo vs. 1.1% per year with aspirin, P=0.22) or serious adverse events. CONCLUSIONS: In this study, aspirin, as compared with placebo, did not significantly reduce the rate of recurrence of venous thromboembolism but resulted in a significant reduction in the rate of major vascular events, with improved net clinical benefit. These results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism. (Funded by National Health and Medical Research Council [Australia] and others; Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
Kahn, S. R., Shrier, I., Julian, J. A., Ducruet, T., Arsenault, L., Miron, M.-J., Roussin, A., Desmarais, S., Joyal, F., Kassis, J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00004 · Cited by 854
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Cited by
Items 201–300 of 600
Platelet integrin αIIbβ3 plays a key role in a venous thrombogenesis mouse model
Adair, B. D., Field, C. O., Alonso, J. L., Xiong, J.-P., Deng, S., Ahn, H.-S., Mashin, E., Clish, C. B., Agthoven, J. F. V., Yeager, M. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52869-3 · Cited by 20
An Open-Set Few-Shot Class Incremental Learning Framework for Specific Emitter Identification
Zhang, T., Shen, X., Shang, Z., Ding, G., Wu, H., & Qiao, X. (2025) · IEEE Transactions on Cognitive Communications and Networking · doi:10.1109/tccn.2025.3565589 · Cited by 20
Ljungqvist, M., Holmström, M., Kieler, H., Odeberg, J., & Lärfars, G. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.11.039 · Cited by 20
Yuki, T., Ishihara, S., Yashima, K., Kawaguchi, K., Fujishiro, H., Miyaoka, Y., Yuki, M., Kushiyama, Y., Yasugi, A., Shabana, M., et al. (2017) · Current Therapeutic Research · doi:10.1016/j.curtheres.2017.03.006 · Cited by 20
Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis
Hsu, C., Brahmandam, A., Brownson, K. E., Huynh, N., Reynolds, J., Lee, A. I., Fares, W. H., & Chaar, C. I. O. (2019) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2018.10.020 · Cited by 20
Wu, Q., Yao, X., Chen, H., Liu, Z., Li, T., Fan, X., Zhang, G., Yu, L., Chen, M., Xu, C., et al. (2020) · Journal of Cancer · doi:10.7150/jca.49001 · Cited by 20
Treatment patterns of venous thromboembolism in a real-world population: The Q-VTE study cohort
Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.07.002 · Cited by 20
Wolff, G., Navarese, E. P., Brockmeyer, M., Lin, Y., Karathanos, A., Kołodziejczak, M. M., Kubica, J., Polzin, A., Zeus, T., Westenfeld, R., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.088 · Cited by 20
Wallace, R. A., Anderson, M. A., See, K., Gorelik, A., Irving, L. B., & Manser, R. L. (2017) · Internal Medicine Journal · doi:10.1111/imj.13382 · Cited by 20
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Fatemi, N., Karimpour, M., Bahrami, H., Zali, M. R., Chaleshi, V., Riccio, A., Mojarad, E. N., & Totonchi, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1329244 · Cited by 19
A Robust Semi-Supervised Broad Learning System Guided by Ensemble-Based Self-Training
Guo, J., & Chen, C. L. P. (2024) · IEEE Transactions on Cybernetics · doi:10.1109/tcyb.2024.3393020 · Cited by 19
Thrombophilia Testing, Recurrent Thrombosis, and Women’s Health
Piazza, G. (2014) · Circulation · doi:10.1161/circulationaha.113.007664 · Cited by 19
Pulmonary Embolism and Deep Vein Thrombosis
Hanna, E. B. (2017) · Wiley eBooks · doi:10.1002/9781119233503.ch21 · Cited by 19
Wang, J., & Zhu, C. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s103184 · Cited by 19
Gaertner, S., Cordeanu, E., Mirea, C., Frantz, A., Auger, C., Bilbault, P., Ohlmann, P., Schini‐Kerth, V. B., & Stéphan, D. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.055 · Cited by 19
Extended Treatment of Venous Thromboembolism
Connors, J. M. (2013) · New England Journal of Medicine · doi:10.1056/nejme1215678 · Cited by 19
Coleman, C. I., Limone, B. L., Bookhart, B. K., Mody, S. H., & Nutescu, E. A. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.02.006 · Cited by 18
“Moreover, aspirin [40,41] and the novel oral anticoagulants, rivaroxaban [1], dabigatran [42] and apixaban [43], have all been evaluated for extended duration prophylaxis after an initial period of therapy, and now offer an alternative to warfarin and other vitamin K antagonists (VKAs).”
BackgroundMethodResultInfluentialWeitz, J. I., & Chan, N. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1679906 · Cited by 18
Madridano, O., del Toro, J., Lorenzo, A., Martín, M., Cerezo, J. G., Hernández, L. M., Prandoni, P., Monréal, M., Arcelus, J. I., Arroyo, M., et al. (2015) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2014.11.002 · Cited by 18
Statins and prevention of venous thromboembolism: Myth or reality?
Gaertner, S., Cordeanu, E., Nouri, S., Mirea, C., & Stéphan, D. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.11.007 · Cited by 18
Reproductive issues in women on direct oral anticoagulants
Beyer‐Westendorf, J., & Marten, S. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12512 · Cited by 18
Khan, F. A., Rahman, A. A., Tritschler, T., Carrier, M., Kearon, C., Weitz, J. I., Schulman, S., Couturaud, F., Becattini, C., Agnelli, G., et al. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1690-8728 · Cited by 18
Self-citationA Hybrid of Generative and Discriminative Models Based on the Gaussian-Coupled Softmax Layer
Hayashi, H. (2024) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2024.3358113 · Cited by 18
Tang, A., Zak, S. G., Waren, D. P., Iorio, R. R., Slover, J. D., Bosco, J. A., & Schwarzkopf, R. M. (2020) · The Journal of Knee Surgery · doi:10.1055/s-0040-1716377 · Cited by 18
Signorelli, S. S., Conti, G. O., Fiore, M., Cangiano, F., Zuccarello, P., Gaudio, A., & Ferrante, M. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s236286 · Cited by 18
Rivaroxaban for the Treatment of Pulmonary Embolism
Vanassche, T., & Verhamme, P. B. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0041-4 · Cited by 18
Cardiovascular Risk Factors and Venous Thromboembolism: Is there a Connection?
García‐Raso, A., Montero, S., Belén, A., & Pilar, L. S. (2013) · Cited by 17
Recent Pathophysiological Insights Are Advancing the Treatment of Venous Thromboembolism
Singh, S., Kumar, P., Yadav, S. K., Jaffer, F. A., & Reed, G. L. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.12.004 · Cited by 17
Joalland, F., de BOYSSON, H., Darnige, L., Johnson, A., Jeanjean, C., Chèze, S., Augustin, A. J., Auzary, C., & Geffray, L. (2014) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2014.04.012 · Cited by 17
Sharifi, M., Freeman, W. K., Bay, R. C., Sharifi, M., & Schwartz, F. N. (2015) · Vascular Medicine · doi:10.1177/1358863x14553882 · Cited by 17
Li, X., Zhao, K., Ma, N., Sun, S., Miao, Z., & Zhao, Z. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2298-z · Cited by 17
Antiplatelet therapy in prevention of cardio- and venous thromboembolic events
Steinhubl, S. R., Eikelboom, J. W., Hylek, E. M., Dauerman, H. L., Smyth, S. S., & Becker, R. C. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-1023-8 · Cited by 17
Self-citationDas, S., Kolahdouzi, M., Özparlak, L., Hickie, W., & Etemad, A. (2023) · IEEE International Joint Conference on Biometrics (IJCB) · doi:10.1109/ijcb57857.2023.10449301 · Cited by 17
Guenther, F., Herr, N., Mauler, M., Witsch, T., Roming, F., Hein, L., Boeynaems, J. M., Robaye, B., Idzko, M., Bode, C., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12206 · Cited by 16
Sodeifian, G., & Razmimanesh, F. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1464956 · Cited by 16
Rodríguez‐Núñez, N., Ruano‐Raviña, A., Lama, A., Ferreiro, L., Ricoy, J., Álvarez-Dobaño, J. M., Antelo, J. S., Toubes, M. E., Rábade, C., Golpe, A., et al. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1634 · Cited by 16
Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
Díaz, T., Trachtenberg, B. H., Abraham, S. J., Rao, K. S. J., & Durant-Archibold, A. A. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.562708 · Cited by 16
Aspirin and recurrent venous thromboembolism
Prandoni, P., Noventa, F., & Milan, M. (2013) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355512475040 · Cited by 16
Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis
Candel, C. S., Hellstern, V., Beitlich, T., Pérez, M. A., Bäzner, H., & Henkes, H. H. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419895157 · Cited by 16
Wakefield, T. W., Andrea, T., & Henke, P. K. (2014) · Circulation · doi:10.1161/circulationaha.114.012235 · Cited by 16
A Survey of Transformer Enabled Time Series Synthesis
Sommers, A., Cummins, L., Mittal, S., Rahimi, S., Seale, M. A., Jaboure, J., & Arnold, T. (2024) · IEEE International Conference on Collaboration and Internet Computing (CIC) · doi:10.1109/cic62241.2024.00018 · Cited by 15
Mavromanoli, A. C., Barco, S., & Konstantinides, S. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12509 · Cited by 16
Omari, A. M., Parcells, B. W., Levine, H. B., Seidenstein, A., Parvizi, J., & Klein, G. R. (2021) · The Bone & Joint Journal · doi:10.1302/0301-620x.103b6.bjj-2020-2436.r1 · Cited by 15
Marcucci, M., Iorio, A., & Douketis, J. D. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-012-0225-2 · Cited by 15
Sultan, S. M., Jackson, D. S., Erhard, H. A., Greenspun, D. T., Benacquista, T., Garfein, E. S., & Weichman, K. E. (2017) · Journal of Reconstructive Microsurgery · doi:10.1055/s-0037-1608629 · Cited by 15
Li, A., Khatib, R., Lopes, L. C., Aloweni, F. B. A. B., Lu, L., He, Q., Wu, J., Zhang, P., Tang, Y., Pavalagantharajah, S., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015371 · Cited by 14
Haj, A. K., Paul, D. S., Jurgens, S. J., Eswaran, H., Weng, L.-C. C., Ryu, J. H., Espada, A. R., Chaudhry, S. A., Feingold, L. M., Burke, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62789-5 · Cited by 14
An Update on the “Novel” and Direct Oral Anticoagulants, and Long-Term Anticoagulant Therapy
Djulbegovic, M., & Lee, A. I. (2018) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2018.04.010 · Cited by 14
The prevention of venous thromboembolism recurrence in the elderly: a still open issue
Palareti, G., & Poli, D. (2018) · Expert Review of Hematology · doi:10.1080/17474086.2018.1526667 · Cited by 14
Antithrombotic Therapy for Prevention of Various Thrombotic Diseases
Goto, S., & Tomita, A. (2013) · Drug Development Research · doi:10.1002/ddr.21116 · Cited by 14
Shamalov, N. A., & Kustova, M. A. (2014) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2014-2s-42-49 · Cited by 14
JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis
Tamura, Y., Kusunose, K., Yamashita, Y., Akagi, T., Atsukawa, M., Fukumoto, Y., Goda, A., Goto, S., Hatano, M., Ikeda, M., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-1144 · Cited by 14
Silva, V. S., & Gonçalves, P. P. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.10.014 · Cited by 13
Cerebral Sinovenous Thrombosis in Infants and Children: A Practical Approach to Management
Mandel‐Shorer, N., Sabapathy, C. A., Krishnan, P., Sharma, M., Goldenberg, N. A., Brandão, L. R., & Moharir, M. D. (2022) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2022.100993 · Cited by 13
Keller, K., Kohring, C., Farmakis, I. T., Valerio, L., Barco, S., Bätzing, J., Akmatov, M. K., Konstantinides, S., Münzel, T. F., Hobohm, L., et al. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.04.008 · Cited by 13
Predicting venous thrombosis in patients undergoing elective splenectomy
Szász, P., Ardestani, A., Shoji, B. T., Brooks, D. C., & Tavakkoli, A. (2019) · Surgical Endoscopy · doi:10.1007/s00464-019-07007-2 · Cited by 13
Pulmonary embolism: current and new treatment options
Walter, R. J., Moores, L. K., & Jiménez, D. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.936931 · Cited by 13
Antiplatelet agents for the treatment of deep venous thrombosis
Flumignan, C. D. Q., Flumignan, R. L., & Baptista-Silva, J. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012369 · Cited by 13
Quon, P., Le, H. H., Raymond, V., Mtibaa, M., & Moshyk, A. (2016) · Journal of Medical Economics · doi:10.3111/13696998.2016.1141780 · Cited by 12
Role of platelet count in a murine stasis model of deep vein thrombosis
Mathews, R., Setthavongsack, N., Le-Cook, A., Kaempf, A. J., Loftis, J. M., Woltjer, R. L., Lorentz, C. U., Revenko, A. S., Hinds, M. T., & Nguyen, K. P. (2023) · Platelets · doi:10.1080/09537104.2023.2290916 · Cited by 12
Imberti, D., Pomero, F., & Mastroiacovo, D. (2020) · Blood transfusion · doi:10.2450/2019.0265-18 · Cited by 12
Management of idiopathic venous thromboembolism
Cosmi, B. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1248406 · Cited by 12
Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants
Tritschler, T., Castellucci, L. A., van Es, N., Aujesky, D., & Gal, G. L. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15225 · Cited by 12
Zou, H., Li, Y., & Xu, G. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1637-y · Cited by 12
Report of the American Heart Association (AHA) Scientific Sessions 2012, Los Angeles
Fujita, J. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1490 · Cited by 11
Joint Diffusion Models in Continual Learning
Skierś, P., & Deja, K. R. (2025) · IEEE/CVF International Conference on Computer Vision (ICCV) · doi:10.1109/iccv51701.2025.00417 · Cited by 11
Staško, J., Hollý, P., & Kubisz, P. (2022) · Expert Review of Hematology · doi:10.1080/17474086.2022.2030217 · Cited by 11
van der Bijl, N., Klok, F. A., Huisman, M. V., Roos, A., & Kroft, L. J. M. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13289 · Cited by 11
Kanyi, J., Karwa, R., Pastakia, S. D., Manji, I., Manyara, S. M., & Saina, C. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028016686106 · Cited by 11
Bench to bedside: new developments in our understanding of the pathophysiology of thrombosis
Key, N. S. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0898-8 · Cited by 11
Emulations of oncology trials using real-world data: a systematic literature review
Rider, J. R., Wasserman, A., Slipski, L., Carrigan, G. J., Harvey, R. A., Jiao, X., McRoy, L., Pace, N. D., Becnel, L. B., Bruno, A. S., et al. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae346 · Cited by 10
The fibrinolytic system in disease: From molecular pathways to clinical outcomes
Alibrahim, M. N., Sahli, K. A., & Alshehri, F. S. (2025) · Thrombosis Research · doi:10.1016/j.thromres.2025.109504 · Cited by 11
Thromboinflammation as a Driver of Venous Thromboembolism
Gauchel, N., Krauel, K., Hamad, M. A., Bode, C., & Duerschmied, D. (2021) · Hämostaseologie · doi:10.1055/a-1661-0257 · Cited by 10
Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
Moodley, O., & Goubran, H. A. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0063-z · Cited by 10
Bozkurt, H., Ölmez, T., Bulut, C. İ., Sert, Ö. Z., Keklikkıran, Z. Z., Karaköse, E., Senger, A. S., Akbulut, S., Polat, E., & Duman, M. (2019) · Gastroenterology Review · doi:10.5114/pg.2019.88622 · Cited by 10
Wustrow, I., Ebner, C., Langwieser, N., Haller, B., Luppa, P. B., Bradaric, C., Bongiovanni, D., Stundl, A., Laugwitz, K., Ibrahim, T., et al. (2020) · Platelets · doi:10.1080/09537104.2020.1754380 · Cited by 10
Tratamiento de la trombosis venosa profunda de extremidades inferiores
Trujillo‐Santos, J. (2020) · Revista Clínica Española · doi:10.1016/j.rce.2020.05.009 · Cited by 10
Signorelli, S. S., Conti, G. O., Fiore, M., Elfio, M. G., Cristaldi, A., Nicolosi, I., Zuccarello, P., Zanoli, L., Gaudio, A., Raimondo, D. D., et al. (2020) · Antioxidants · doi:10.3390/antiox9121217 · Cited by 10
Pellegrini, V. D. (2015) · JBJS Reviews · doi:10.2106/jbjs.rvw.n.00111 · Cited by 10
Secondary Prevention of Venous Thromboembolism: One Regimen May Not Fit All
Blondon, M., & Bounameaux, H. (2015) · Circulation · doi:10.1161/circulationaha.115.019310 · Cited by 10
Qiu, C., Huang, L., Wang, Y., Hu, S., Zhong, W., Lang, D., Wang, X., Zhao, W., Lu, W., Jiang, J., et al. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.109197 · Cited by 9
Toward Deep Semi-Supervised Continual Learning: A Unified Survey for Scalable and Adaptive AI
Jalal, M. E., & Elmaghraby, A. S. (2025) · IEEE Access · doi:10.1109/access.2025.3556569 · Cited by 9
Pharmacogenetics and Pharmacogenomics Impact on Aspirin Response
Siddiqui, M. A., Jain, C., Usmani, A., Hafeez, A., Khalid, M., & Mujahid, M. (2024) · Pharmaceutical science. · doi:10.5772/intechopen.113026 · Cited by 9
System Condition Monitoring Based on a Standardized Latent Space and the Nataf Transform
Oliveira-Filho, A., Zemouri, R. M., Pelletier, F., & Tahan, A. S. (2024) · IEEE Access · doi:10.1109/access.2024.3370949 · Cited by 9
Update in venous thromboembolism pathophysiology, diagnosis, and treatment for surgical patients
Coleman, D. M., Andrea, T., & Henke, P. K. (2015) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2015.04.003 · Cited by 9
New insights into treatment of venous thromboembolism
Moll, S. (2014) · Hematology · doi:10.1182/asheducation-2014.1.297 · Cited by 9
Changing paradigms in the management of deep vein thrombosis
Lang, K. J., Saha, P., Roberts, L. N., & Arya, R. (2015) · British Journal of Haematology · doi:10.1111/bjh.13431 · Cited by 9
Thrombo-prophylaxis in acutely ill medical and critically ill patients
Joshi, R. P., Saigal, S., Sharma, J. P., & Singh, D. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.133902 · Cited by 9
Maloney, J. P., Branchford, B. R., Brodsky, G. L., Cosmic, M. S., Calabrese, D. W., Aquilante, C. L., Maloney, K. W., González, J. R., Zhang, W., Moreau, K. L., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600344r · Cited by 9
Update on Pharmacologic Therapy for Pulmonary Embolism
Harikrishnan, P., Palaniswamy, C., & Aronow, W. S. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413506612 · Cited by 9
Drug Treatment of Venous Thromboembolism in the Elderly
Boey, J. P., & Gallus, A. S. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0378-x · Cited by 9
Self-citationAnticoagulation is Not Mandatory After Stenting for Malignant Superior Vena Cava Syndrome
Thony, F., Fagedet, D., Michoud, M., Moro‐Sibilot, D., Ferretti, G., & Rodiere, M. (2014) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-014-0902-5 · Cited by 9
Verlängerte Sekundärprophylaxe nach venöser Thromboembolie
Bauersachs, R. M. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-113679 · Cited by 8
Zou, P., Li, H., Cai, J., Li, C., Chen, Z., & Li, X. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1635030 · Cited by 8
Identity-Aware Variational Autoencoder for Face Swapping
Li, Z., Zhang, Z., He, S., Meng, Q., Zhang, S., Zhong, B., & Ji, R. (2024) · IEEE Transactions on Circuits and Systems for Video Technology · doi:10.1109/tcsvt.2024.3349909 · Cited by 8
Guidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery
Sobreira, M. L., Marques, M. A., Paschôa, A. F., Ribeiro, A. J. A., Casella, I. B., Burihan, M. C., Matielo, M. F., Soares, R. D. A., de Araújo, W. J. B., Joviliano, E. É., et al. (2024) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202301072 · Cited by 8
Carron, M., Tamburini, E., Pettenuzzo, T., Zarantonello, F., Campello, E., Navalesi, P., & Simioni, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-02171-z · Cited by 8
Contemporary Treatment of Venous Thromboembolic Disease
Galanis, T., & Merli, G. J. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.09.007 · Cited by 8
Management of Pulmonary Embolism: State of the Art Treatment and Emerging Research
Esponda, O. L., & Tafur, A. J. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0229-6 · Cited by 8
Liew, A., & Douketis, J. D. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.770838 · Cited by 8
Metadata
- Authors
- Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A., & Simes, J.
- Affiliations
- Prince of Wales Hospital (AU)
- Population Health Research Institute (CA)
- The University of Sydney (AU)
- South Australia Pathology (AU)
- Auckland City Hospital (NZ)
- The Alfred Hospital (AU)
- St.John's Medical College Hospital (IN)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-11-22
- Volume
- 367
- Issue
- 21
- Pages
- 1979-1987
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2162531249
- Cited by
- 563
- References
- 24
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 39 · 2023: 24 · 2022: 25 · 2021: 33 · 2020: 37 · 2019: 30 · 2018: 35 · 2017: 49 · 2016: 51 · 2015: 56 · 2014: 60 · 2013: 69 · 2012: 8
- FWCI
- 41.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- low-dose aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, anticoagulation discontinuation, secondary prevention, cardiovascular events, bleeding risk, major vascular events, net clinical benefit, thromboprophylaxis, stroke, myocardial infarction
- MeSH terms
- Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk, Incidence, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.